All
- All
- Articles
- Calendar
- Compliance
- Newsletter
- Position Statements
- Press Release
- Regulatory
- Uncategorized
The Long-Term Vision for AAHP
By Eric Foxman, AAHP secretary October 1, 2017 During the course of the summer, AAHP president Mark Land lead the various association committees in an...
Market Research Roundup
By Eric Foxman, AAHP secretary October 1, 2017 The last weeks have seen a number of market research studies published that provide background, analysis, and...
Belladonna: A Clinical Snapshot
By Todd Hoover, MD September 1, 2017 The original proving of belladonna was conducted by Dr. Samuel Hahnemann, who found it to become a commonly...
How is Homeopathic Belladonna Made?
By Mark Land, AAHP president September 1, 2017 Belladonna, more commonly known as deadly nightshade, Atropa belladonna, devil's cherries, devil's herb, divale, dwale, dwayberry, great morel,...
What’s New at FDA?
By Mark Land, AAHP president September 1, 2017 I took a course several years ago titled Regulatory Intelligence. The first thing the professor said was,...
When Anti-Homeopathy Skeptics Strike
By Deborah Kelly and Alissa Gould, PR Managers, Boiron USA September 1, 2017 It’s typical for skeptics to fire away at anyone who posts or...
The Road to OTC Monograph Reform
By Barbara A. Kochanowski, senior vice president of regulatory and scientific affairs Consumer Healthcare Products Association August 1, 2017 For the past three years, the...
